China
Wisonic Medical is a leading national high-tech enterprise in the healthcare technology sector, specializing in product R&D, manufacturing, and marketing. Established in 2012 and headquartered in Shenzhen, China, Wisonic is committed to delivering life-information support, intelligent ultrasound imaging, and cloud medical care on a global scale. The company's value proposition, "professional focus, specialized products," underscores its dedication to addressing the needs of high-end and medium-range medical institutions worldwide.
Wisonic's strength lies in its professional focus and digital intelligence, evident in its continuous pursuit of excellence in technological research and product development. The company has forged partnerships with Tsinghua University and top-ranked hospitals, establishing joint laboratories for cutting-edge technologies. Notably, Wisonic was a pioneer in applying IoT technology to medical devices and in 2019, established the Guangdong Cloud Ultrasonic Technology Research Center.
The company's recent CNY40.00M Post-IPO Equity investment on 24 December 2019 involved prominent investors such as Addor Capital and the National SME Development Fund (JiangSu), reflecting investor confidence in Wisonic's vision and capabilities. Supported by China's Ministry of Science and Technology for multiple major projects, Wisonic is at the forefront of driving breakthroughs in China’s medical technology development.
Wisonic's mission is to explore, practice, innovate, and improve in the life and health field, with a commitment to benefiting the world of healthcare upon achieving success.
